C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2002
10/24/2002	WO2002083850A2 Vascular endothelial growth factor 2
10/24/2002	WO2002083849A2 Vascular endothelial growth factor 2
10/24/2002	WO2002083847A2 Cdna encoding the human alpha2 delta4 calcium channel subunit
10/24/2002	WO2002083843A2 Outer membrane associated polypeptides
10/24/2002	WO2002083841A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/24/2002	WO2002083838A2 Elimination of endogenous porcine retrovirus
10/24/2002	WO2002083736A2 G-protein coupled receptor molecules and uses thereof
10/24/2002	WO2002083735A1 Novel receptor protein and dna thereof
10/24/2002	WO2002083734A2 Modified calcitonin
10/24/2002	WO2002083733A2 Polynucleotides and polypeptides of the ifnalpha-6 gene
10/24/2002	WO2002083731A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/24/2002	WO2002083730A1 Novel protein irsal and gene irsal encoding this protein
10/24/2002	WO2002083729A2 Polypeptides derived from amyloid precursor peptide (app) and their uses
10/24/2002	WO2002083728A2 Splice variant
10/24/2002	WO2002083727A2 Nucleic acid sequences of hyperplasies and tumors of the thyroid
10/24/2002	WO2002083726A2 A novel zinc finger protein and uses thereof
10/24/2002	WO2002083725A1 Novel stress protein with chaperone activity
10/24/2002	WO2002083724A1 Antigens for raising an immune response against rickettsieae and ehrlichieae pathogens
10/24/2002	WO2002083723A2 Polypeptides from h. influenzae homologous to a surface-exposed protein of neisseria meningitidis
10/24/2002	WO2002083722A2 Methods and means for use of hla-dq restricted t-cell receptors and hla-dq-binding prolamine-derived peptides
10/24/2002	WO2002083721A1 Protein cluster v
10/24/2002	WO2002083717A1 Induction of spawning in crustacea
10/24/2002	WO2002083715A1 Method and apparatus for fractional separation of proteins from plant material
10/24/2002	WO2002083714A2 Method and system for optimizing multi-epitope nucleic acid constructs and peptides encoded thereby
10/24/2002	WO2002083712A2 Transporters and ion channels
10/24/2002	WO2002083711A2 Molecular mimetics of meningococcal b epitopes which elicit functionally active antibodies
10/24/2002	WO2002083710A2 Removal of bacterial endotoxin in a protein solution by immobilized metal affinity chromatography
10/24/2002	WO2002083707A1 Tub antisense constructs
10/24/2002	WO2002083705A1 Socs-1 gene methylation in cancer
10/24/2002	WO2002083704A1 Vascular endothelial growth factor 2
10/24/2002	WO2002083186A1 Nuclear receptor-mediated introduction of a pna into cell nuclei
10/24/2002	WO2002083185A1 Method of gene transfer via vascular system or ureter
10/24/2002	WO2002083183A2 Stimulation of the immune system
10/24/2002	WO2002083181A1 Novel compositions and uses therefor
10/24/2002	WO2002083180A1 Elongated and multiple spacers in activatible prodrugs
10/24/2002	WO2002083169A1 Modified staphylococcal enterotoxins and expression systems therefore
10/24/2002	WO2002083164A2 Method and composition for prophylaxis of diabetes
10/24/2002	WO2002083162A1 Use of a cd8+ t cell inhibitory agent in the presence of a cd4+ t cell inhibitory agent for inhibition of transplant rejection
10/24/2002	WO2002083081A2 Prostate cancer-related compositions, methods and kits based on dna macroarray protemics platforms
10/24/2002	WO2002083080A2 Method of treating arthritis using lentiviral vectors in gene therapy
10/24/2002	WO2002083077A2 Novel human gene relating to respiratory diseases, obesity, and inflammatory bowel disease
10/24/2002	WO2002083074A2 Methods for the treatment of hepatic disorders
10/24/2002	WO2002083072A2 Methods and compositions for stable transgenic plant pharmaceuticals and their use as contraceptives
10/24/2002	WO2002083070A2 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
10/24/2002	WO2002083069A2 Recombinant proteins of orientia tsutsugamushi
10/24/2002	WO2002083068A2 Nucleic acid and corresponding protein entitled 121p2a3 useful in treatment and detection of cancer
10/24/2002	WO2002082986A1 Imaging of a region in a scattering medium
10/24/2002	WO2002082908A1 Method of treating arthritis using lentiviral vectors in gene therapy
10/24/2002	WO2002082904A2 Method of treating or retarding the development of blindness
10/24/2002	WO2002082889A1 A method to control the ripening of papaya fruit and confer disease resistance to papaya plants
10/24/2002	WO2002074941A8 Reporter virus comprising heterologous envelope proteins
10/24/2002	WO2002064023A3 Fra-1 expression in brain cancer
10/24/2002	WO2002062995A3 Human dorsal root receptor-like g protein-coupled receptor
10/24/2002	WO2002061061A3 Inhibition of interleukin-1-beta secretion by card proteins
10/24/2002	WO2002060931A3 A fimbria-like gene in bifidobacteria
10/24/2002	WO2002055669A3 Regulation of target protein activity through modified proteins
10/24/2002	WO2002040038A3 M. tuberculosis chaperonin 10 and uses thereof
10/24/2002	WO2002032397A9 Electroprocessing in drug delivery and cell encapsulation
10/24/2002	WO2002024729A3 Haemophilus influenzae basb202 polypeptide, production, vaccine and diagnostic use
10/24/2002	WO2002022777A3 Cellular genes involved in oncogenesis, products of said genes and their diagnostic and therapeutic uses
10/24/2002	WO2002004521A3 Proteins with integrin-like activity
10/24/2002	WO2002002630A3 Hcn polypeptides and polynucleotides and their use in therapy
10/24/2002	WO2002000913A9 MODULATION OF β-AMYLOID LEVELS BY β-SECRETASE BACE2
10/24/2002	WO2002000722A3 Human calcium channels (48000; 52920) and uses thereof
10/24/2002	WO2001096399A3 Novel interferon-induced tetraspan protein and nucleic acids encoding same
10/24/2002	WO2001077375A8 Diagnosis of diseases associated with gene regulation
10/24/2002	WO2001074848A3 Immunodominant acetylcholine receptor alpha subunit peptides, complexes thereof with mhc class ii components and their use
10/24/2002	WO2001073038A3 Method for the biotechnological production of l-alaninol
10/24/2002	WO2001068911A8 Diagnosis of diseases associated with the cell cycle
10/24/2002	WO2001062797A3 G protein-coupled receptors
10/24/2002	WO2001062793A9 Estrogen receptor beta variants and methods of detection thereof
10/24/2002	WO2001061005A3 Molecules of the pyrin domain protein family and uses thereof
10/24/2002	WO2001059114A9 Tumor suppressor gene, p47ing3
10/24/2002	WO2001057189A9 Fas pathway genes
10/24/2002	WO2001055337A3 Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides
10/24/2002	WO2001025484A3 Methods to inhibit or enhance the binding of viral dna to genomic host dna
10/24/2002	WO2001008720A9 Hypocretin and hypocretin receptors in regulation of sleep and related disorders
10/24/2002	WO1999064449A3 Cell-permeable peptide
10/24/2002	WO1999050288A3 Mammalian blood loss-induced gene, kd312
10/24/2002	US20020157142 Herbicide target genes and methods
10/24/2002	US20020157140 Esr1 - a plant gene that can promote plant regeneration and transformation
10/24/2002	US20020157137 Nucleic acids that control reproductive development in plants
10/24/2002	US20020157136 Plant having altered environmental stress tolerance
10/24/2002	US20020157131 Cytoplasmic inhibition of gene expression and expression of a foreign protein in a monocot plant by a plant viral vector
10/24/2002	US20020157127 Transgene that comprises DNA encoding for epitope tagged TATA box binding protein (TBP), production of transgenic animals which express epitope-tagged TBP and use of epitope tagged TBP for isolating and affinity purifying transcription factors
10/24/2002	US20020157126 Transgenic nonhuman animal whose genome contains a nucleic acid sequence comprising a truncated Activin Type II receptor gene and a muscle-specific promoter operably linked and integrated into genome of animal; increased muscle mass
10/24/2002	US20020157125 Growth differentiation factor-8
10/24/2002	US20020157124 Transgenic rodents and rodent cell lines expressing HIV co-receptors
10/24/2002	US20020157121 Propagation of human hepatocytes in non-human animals
10/24/2002	US20020157120 Circularly permuted fluorescent protein indicators
10/24/2002	US20020157119 Identification of activated receptors and ion channels
10/24/2002	US20020157118 Human neurofilament genes may be introduced into such genetically non-human animals to produce improved models of physiology of human neurofilament proteins which may be used to study human neurodegenerative disorders
10/24/2002	US20020156773 Soluble HLA ligand database utilizing predictive algorithms and methods of making and using same
10/24/2002	US20020156266 Sodium phosphate cotransporter expressed on apical surface of intestinal epithelial cells (huNpt2B) and polypeptides related thereto
10/24/2002	US20020156265 DNA encoding a GABABR2 polypeptide and uses thereof
10/24/2002	US20020156263 Plurality of cDNAs which are differentially expressed in breast cancer and which may be used to diagnose, to stage, to treat, or to monitor treatment of subject with breast cancer
10/24/2002	US20020156260 Gene encoding a polypeptide having pre-B cell growth-supporting ability
10/24/2002	US20020156258 Transcription factor of MHC class II genes, substances capable of inhibiting this new transcription factor and medical uses of these substances
10/24/2002	US20020156257 Rab protein alternative splice form and nucleic acid molecules encoding novel splice form, all of which are useful in development of human therapeutics and diagnostic compositions and methods
10/24/2002	US20020156256 Nucleic acid and amino acid sequences of a novel H-rev107-like protein for use in diagnosis, prevention, and treatment of cancer and autoimmune disorders

1 ... 1732 1733 1734 1735 1736 1737 1738 1739 1740 1741 1742 1743 1744 1745 1746 1747 1748 1749 1750 1751 1752 ... 2916